Elliot Norry - 17 Jan 2023 Form 4 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Chief Medical Officer
Signature
/s/ Elliot Norry
Issuer symbol
ADAP
Transactions as of
17 Jan 2023
Transactions value $
$0
Form type
4
Filing time
17 Jan 2023, 20:03:19 UTC
Previous filing
12 Jan 2023
Next filing
12 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADAP Option to purchase Ordinary Shares Award $0 +1,407,072 $0.000000 1,407,072 17 Jan 2023 Ordinary Shares 1,407,072 $0.3100 Direct F1, F2
transaction ADAP Option to purchase Ordinary Shares Award $0 +314,256 $0.000000 314,256 17 Jan 2023 Ordinary Shares 314,256 $0.001200 Direct F3, F4, F5
transaction ADAP Option to purchase Ordinary Shares Award $0 +193,344 $0.000000 193,344 17 Jan 2023 Ordinary Shares 193,344 $0.001200 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price was converted from GBP0.26 based on an exchange rate of $U.S. 1.219333 to GBP1.00. The actual exercise price will be the pounds sterling amount.
F2 Exercisable as to 351,768 Ordinary Shares on January 17, 2024 and will be exercisable as to the remainder in monthly installments of 29,310 Ordinary Shares on the seventeenth of each month from February 17, 2024 through December 17, 2026 and 29,454 Ordinary Shares on January 17, 2027.
F3 The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of $U.S. 1.219333 to GBP1.00. The actual exercise price will be the pounds sterling amount.
F4 Exercisable as to 78,564 Ordinary Shares on January 17, 2024 and will be exercisable as to the remainder in annual installments of 78,564 Ordinary Shares on the seventeenth of each January from January 17, 2025 through January 17, 2027.
F5 The expiration date of each annual installment of ordinary shares is March 15 of the calendar year following the year in which that installment becomes exercisable.
F6 The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of $U.S. 1.219333 to GBP1.00. The actual exercise price will be the pounds sterling amount.